# Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer

> **NCT00006046** · PHASE1 · TERMINATED · sponsor: **Ludwig Institute for Cancer Research** · enrollment: 7 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** monoclonal antibody hu3S193

## Key facts

- **NCT ID:** NCT00006046
- **Lead sponsor:** Ludwig Institute for Cancer Research
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-07-12
- **Primary completion:** 2001-10-05
- **Final completion:** 2002-09-24
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** poor recruitment
- **Last updated:** 2023-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006046, "Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00006046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*